Claudio Passino researcher
Passino, Claudio
VIAF ID: 780149198357774940000 (Personal)
Permalink: http://viaf.org/viaf/780149198357774940000
Preferred Forms
- 100 0 _ ‡a Claudio Passino ‡c researcher
-
- 100 1 _ ‡a Passino, Claudio
-
- 100 1 _ ‡a Passino, Claudio
4xx's: Alternate Name Forms (2)
Works
Title | Sources |
---|---|
The breathless heart, 2017: | |
Management of complications of cardiac amyloidosis: 10 questions and answers | |
Markers of arrhythmogenic risk in hypertensive subjects. | |
Markers of fibrosis, inflammation, and remodeling pathways in heart failure. | |
Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imaging. | |
Measurement of the pro-hormone of brain type natriuretic peptide (proBNP): methodological considerations and pathophysiological relevance. | |
Medium-term effect of sublingual l-glutathione supplementation on flow-mediated dilation in subjects with cardiovascular risk factors. | |
Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure | |
The metabolic exercise test data combined with Cardiac And Kidney Indexes (MECKI) score and prognosis in heart failure. A validation study. | |
Mineralocorticoid receptor antagonists for heart failure: a real-life observational study. | |
The month after a novel tale on eplerenone, but with a different ending | |
Multiparametric Echocardiography Scores for the Diagnosis of Cardiac Amyloidosis | |
Myocardial damage in a mitochondrial myopathy patient with increased ergoreceptor sensitivity and sympatho-vagal imbalance. | |
Myocardial fibrosis as a early cardiac marker of disease in patients with lamin A/C mutations. | |
Myocardial signal intensity decay after gadolinium injection: a fast and effective method for the diagnosis of cardiac amyloidosis | |
N-terminal fragment of B-type natriuretic peptide predicts coexisting subclinical heart and vessel disease. | |
N-terminal prob-type natriuretic peptide is a marker of vascular remodelling and subclinical atherosclerosis in asymptomatic hypertensives. | |
Natriuretic peptide assays revisited: do we need pro-B-type natriuretic peptide? | |
Natriuretic peptide testing in primary care patients. | |
Natriuretic peptides as biomarkers of cardiac endocrine function in heart failure: new challenges and perspectives. | |
Natriuretic peptides (NPs): Automated electrochemiluminescent immunoassay for N-terminal pro-BNP compared with IRMAs for ANP and BNP in heart failure patients and healthy individuals. | |
Neurohormonal modulation for treatment of cardiac involvement in dystrophinopathies and mitochondrial disease | |
Neutrophil Gelatinase-Associated Lipocalin for Acute Kidney Injury During Acute Heart Failure Hospitalizations: The AKINESIS Study | |
Noncardiovascular death after acute heart failure. Do not lose the war while fighting for the failing heart. | |
Permanent atrial fibrillation affects exercise capacity in chronic heart failure patients | |
Persistence of baroreceptor control of cerebral blood flow velocity at a simulated altitude of 5000 m | |
Plasma leptin and vascular endothelial growth factor (VEGF) in normal subjects at high altitude (5050 m). | |
Predicting readmissions after hospitalization for heart failure: Medical reasoning vs calculators | |
Predictive value of elevated neutrophil-lymphocyte ratio on cardiac mortality in patients with stable coronary artery disease. | |
Prognostic role of β-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database. | |
Prognostic Significance of Central Apneas Throughout a 24-Hour Period in Patients With Heart Failure. | |
Prognostic significance of myocardial extracellular volume fraction in nonischaemic dilated cardiomyopathy | |
Prognostic value of alveolar volume in systolic heart failure: a prospective observational study | |
Prognostic value of combined measurement of brain natriuretic peptide and triiodothyronine in heart failure | |
Prognostic value of indeterminable anaerobic threshold in heart failure. | |
Prognostic value of plasma renin activity in heart failure patients with chronic kidney disease. | |
Recommendations for the clinical use of cardiac natriuretic peptides | |
Reduced hypoxic ventilatory response with preserved blood oxygenation in yoga trainees and Himalayan Buddhist monks at altitude: evidence of a different adaptive strategy? | |
Refractory hyperaldosteronism in heart failure is associated with plasma renin activity and angiotensinogen polymorphism | |
Renal denervation in resistant arterial hypertension: Effects on neurohormonal activation and cardiac natriuretic peptides | |
Renal function and peak exercise oxygen consumption in chronic heart failure with reduced left ventricular ejection fraction. | |
Renin profiling predicts neurohormonal response to sacubitril/valsartan | |
Respiratory and cardiovascular adaptations to progressive hypoxia; effect of interval hypoxic training | |
Respiratory and cerebrovascular responses to hypoxia and hypercapnia in familial dysautonomia | |
Respiratory Training Late After Fontan Intervention: Impact on Cardiorespiratory Performance. | |
Response to letters regarding article, "Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study". | |
The search for efficient diagnostic and prognostic biomarkers of heart failure. | |
Serum gamma-glutamyltransferase as a risk factor of ischemic stroke might be independent of alcohol consumption. | |
Severe heart failure prognosis evaluation for transplant selection in the era of beta-blockers: Role of peak oxygen consumption | |
Sex Profile and Risk Assessment With Cardiopulmonary Exercise Testing in Heart Failure: Propensity Score Matching for Sex Selection Bias | |
Sex-related differences in chronic heart failure. | |
The significance of serum gamma-glutamyltransferase in cardiovascular diseases | |
Silent myocardial damage in cocaine addicts. | |
A simple method for measuring baroreflex sensitivity holds prognostic value in heart failure. | |
Single-shot cardiorenal scintigraphy with 99mTc-tetrofosmin: a dynamic characterization at rest and during adenosine infusion. | |
sST2 Predicts Outcome in Chronic Heart Failure Beyond NT-proBNP and High-Sensitivity Troponin T | |
State of the art of aldosterone immunoassays. A multicenter collaborative study on the behalf of the Cardiovascular Biomarkers Study Group of the Italian Section of European Society of Ligand Assay (ELAS) and Società Italiana di Biochimica Clinica ( | |
State of the art of immunoassay methods for B-type natriuretic peptides: An update. | |
Statin intolerance in heterozygous familial hypercolesterolemia with cardiovascular disease: After PCSK-9 antibodies what else? | |
Surgery casualties: do not leave hearts behind enemy lines. | |
Sympathetic and renin-angiotensin-aldosterone system activation in heart failure with preserved, mid-range and reduced ejection fraction | |
Systematic differences between BNP immunoassays: comparison of methods using standard protocols and quality control materials | |
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches | |
Targeting periodic breathing in heart failure patients, and treating it-gently. | |
Thirty years of the heart as an endocrine organ: physiological role and clinical utility of cardiac natriuretic hormones. | |
Treating chemoreflex in heart failure: modulation or demolition? | |
Upright Cheyne-Stokes Respiration in Patients With Heart Failure | |
Usefulness of High-Sensitive Troponin Elevation After Effort Stress to Unveil Vulnerable Myocardium in Patients With Heart Failure. | |
Ventilation, autonomic function, sleep and erythropoietin. Chronic mountain sickness of Andean natives. | |
Ventricular repolarization is prolonged in nondipper hypertensive patients: role of left ventricular hypertrophy and autonomic dysfunction | |
When gonads talk to the heart sex hormones and cardiac endocrine function |